SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Makers Laboratories - Quaterly Results

26 May 2025 Evaluate
Net sales declined -15.30%  to  Rs. 97.01 million from Rs. 114.53 millions.The Net Loss for the quarter ended March 2025 is Rs. -14.00 millions as compared to Net Loss of Rs. -15.57 millions of corresponding quarter ended March 2024Operating profit Margin for the quarter ended March 2025 slipped to -11.86% as compared to 0.08% of corresponding quarter ended March 2024


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202503 202403 % Var 202503 202403 % Var 202503 202403 % Var
Sales 97.01 114.53 -15.30 429.45 490.89 -12.52 429.45 490.89 -12.52
Other Income 0.25 1.48 -83.11 109.24 11.52 848.26 109.24 11.52 848.26
PBIDT -11.86 0.08 -14925.00 87.15 -26.09 -434.04 87.15 -26.09 -434.04
Interest 0.92 4.61 -80.04 9.40 16.34 -42.47 9.40 16.34 -42.47
PBDT -12.78 -4.53 182.12 77.75 -42.43 -283.24 77.75 -42.43 -283.24
Depreciation 6.92 6.83 1.32 28.46 27.15 4.83 28.46 27.15 4.83
PBT -19.70 -11.36 73.42 49.29 -69.58 -170.84 49.29 -69.58 -170.84
TAX -5.70 4.21 -235.39 2.87 -0.06 -4883.33 2.87 -0.06 -4883.33
Deferred Tax -5.69 4.23 -234.52 2.88 -0.04 -7300.00 2.88 -0.04 -7300.00
PAT -14.00 -15.57 -10.08 46.42 -69.52 -166.77 46.42 -69.52 -166.77
Equity 59.00 59.00 0.00 59.00 59.00 0.00 59.00 59.00 0.00
PBIDTM(%) -12.23 0.07 -17589.99 20.29 -5.31 -481.83 20.29 -5.31 -481.83

Makers Laboratories Share Price

155.80 -4.35 (-2.72%)
13-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1652.00
Dr. Reddys Lab 1235.20
Cipla 1211.30
Zydus Lifesciences 923.10
Lupin 2312.35
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×